Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hashim Hashim

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
Drugs & Aging|December 21, 2005
Solifenacin in overactive bladder: a viewpoint by Hashim HashimHashim Hashim
European Urology|December 28, 2014
Transurethral resection of the prostate for benign prostatic obstruction: will it remain the gold standard?Hashim Hashim, Paul Abrams
Drug Design, Development and Therapy|March 4, 2017
Profile of mirabegron in the treatment of overactive bladder: place in therapyAla'a Sharaf, Hashim Hashim
Drugs|April 20, 2006
Pharmacological management of women with mixed urinary incontinenceHashim Hashim, Paul Abrams
Current Opinion in Urology|June 15, 2007
Overactive bladder: an updateHashim Hashim, Paul Abrams
Expert Review of Clinical Pharmacology|May 17, 2021
Desmopressin acetate the first sublingual tablet to treat nocturia due to nocturnal polyuriaNatasha Alford, Hashim Hashim
Drugs|July 20, 2004
Drug treatment of overactive bladder: efficacy, cost and quality-of-life considerationsHashim Hashim, Paul Abrams
Expert Opinion on Emerging Drugs|May 8, 2010
Emerging drugs for the treatment of benign prostatic obstructionHashim Hashim, Paul Abrams
Expert Review of Clinical Pharmacology|December 19, 2024
Methenamine Hippurate in UTI management: a reemerging pharmacological strategyMehwash Nadeem, Hashim Hashim
Female Pelvic Medicine & Reconstructive Surgery|March 29, 2012
Overactive bladder syndromeHashim Hashim, Paul Abrams
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
Drugs & Aging|December 21, 2005
Solifenacin in overactive bladder: a viewpoint by Hashim HashimHashim Hashim
European Urology|December 28, 2014
Transurethral resection of the prostate for benign prostatic obstruction: will it remain the gold standard?Hashim Hashim, Paul Abrams
Drug Design, Development and Therapy|March 4, 2017
Profile of mirabegron in the treatment of overactive bladder: place in therapyAla'a Sharaf, Hashim Hashim
Drugs|April 20, 2006
Pharmacological management of women with mixed urinary incontinenceHashim Hashim, Paul Abrams
Current Opinion in Urology|June 15, 2007
Overactive bladder: an updateHashim Hashim, Paul Abrams
Expert Review of Clinical Pharmacology|May 17, 2021
Desmopressin acetate the first sublingual tablet to treat nocturia due to nocturnal polyuriaNatasha Alford, Hashim Hashim
Drugs|July 20, 2004
Drug treatment of overactive bladder: efficacy, cost and quality-of-life considerationsHashim Hashim, Paul Abrams
Expert Opinion on Emerging Drugs|May 8, 2010
Emerging drugs for the treatment of benign prostatic obstructionHashim Hashim, Paul Abrams
Expert Review of Clinical Pharmacology|December 19, 2024
Methenamine Hippurate in UTI management: a reemerging pharmacological strategyMehwash Nadeem, Hashim Hashim
Female Pelvic Medicine & Reconstructive Surgery|March 29, 2012
Overactive bladder syndromeHashim Hashim, Paul Abrams
Pageof 14